Genic KRX:123330KOSDAQ
제닉 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked1since Sep 11
In Q2 2026, Genic reported revenue of ₩49.2bn, up 99.6% year on year, and operating profit of ₩10.0bn. Genic (제닉) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 19 with 1 article. It was most often mentioned alongside T&L and Daebongls.
Filing signals Profit +50% Revenue +30% Revenue & profit growth Op. margin 20%+ Screener
Genic quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩49.2bn | +99.6% | ₩10.0bn margin 20.3% | ₩11.2bn |
| Q1 2026 | ₩29.4bn | +64.7% | ₩3.4bn margin 11.6% | ₩3.5bn |
| Q4 2025 derived | ₩12.2bn | -37.4% | ₩104m margin 0.9% | ₩6.1bn |
| Q3 2025 | ₩23.6bn | +55.7% | ₩5.6bn margin 24.0% | ₩5.3bn |
| Q2 2025 | ₩24.6bn | +174.7% | ₩5.5bn margin 22.2% | ₩4.0bn |
| Q1 2025 | ₩17.8bn | +180.2% | ₩3.8bn margin 21.1% | ₩3.5bn |
| Q4 2024 derived | ₩19.4bn | +213.6% | ₩3.6bn margin 18.7% | ₩5.5bn |
| Q3 2024 | ₩15.1bn | +104.4% | ₩2.1bn margin 13.7% | ₩1.9bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Genic top stories 2 weeks, by number of outlets
- 1